MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Consolidator ... Mass Market Scale-up, Global Reach, Public Capital
Consolidators: BioPharmaceuticals
Schering-Plough Corporation
Organization & Developments: Schering
Parents
Schering-Plough Corporation
Children
and Remicade, a treatment for Crohn's disease.
Avonex
In the area of anti-infective and anticancer products, Schering-Plough makes Intron A, a treatment for hepatitis C with 2001 sales of $1.4 billion
Major U.S.-based manufacturer of pharmaceuticals.
Other allergy and respiratory treatments include Clarinex, the firm's next-generation allergy treatment, and Nasonex, a nasal spray for allergies with 2001 sales of $524 million.
Overall, pharmaceuticals account for about 85 percent of company sales.
PEG-Intron, a longer-acting form of Intron A
Schering-Plough also makes drugs to treat cardiovascular, dermatological, and central nervous system disorders.
Schering-Plough Research Institute
Schering:Brands
Temodar, used to treat malignant brain cancer
The company's leading prescription drug is the allergy medication Claritin, with 2001 sales of $3.2 billion.
Jumps
*Key People: Schering
Finance & Acquisition: Schering